Q1 2026 consolidated sales: 13.75 billion won (down 72% YoY from 49.95 billion), operating loss of 8.57 billion won (vs profit of 13.34 billion), net profit of 3.13 billion (down 77% from 13.49 billion)
Prior period errors (revenue recognition, financial asset valuation) corrected, leading to restatement of Q1 2025 financials; weak internal controls exposed
Delisting risk due to audit opinion disclaimer in 2024 resolved: trading suspension lifted in March 2026 after passing substantive review
Dividend policy: targeting ~30% of consolidated net income; continuous dividends since 2016
Core competitiveness: HDC cleaner #1 global market share for 20 years, Korea-China production system, strong customer response
New businesses: wind power (equity method in Honam Wind Power), medical devices (Jungbon Medical) to diversify portfolio
Contingent liabilities: 3 ongoing lawsuits with total claim of 347 million won, considered immaterial